Skip to main content
. 2026 May 20;13:1845722. doi: 10.3389/fmed.2026.1845722

Figure 2.

Kaplan-Meier survival curve showing survival analysis percentages over twelve months for two groups, APCS-PP-DALK in blue and AMP in red, with censored data indicated by marks on each line; both groups show a slight decrease in survival rates, with overall higher survival in the red group toward the end of the study period.

Survival curve of AMP and APCS-PP-DALK groups.